Sun Pharmaceutical Industries' (Sun Pharma) consolidated net profit rose 23.32% to Rs 1011.56 crore on 32.14% rise in total income from operations (net) to Rs 3087.04 crore in Q4 March 2013 over Q4 March 2012.
Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) grew by 32% to Rs 1260 crore in Q4 March 2013 over Q4 March 2012, while sustaining EBITDA margin at 41%.
Sun Pharma said that branded generic sales in India were at Rs 780 crore. Adjusted for the extra sales recorded in the Q4 March 2012, as well as the change in treatment of expected sales returns and treatment of discounts, the underlying sales growth of the domestic formulation business is 16%.
US finished dosage sales grew by 63% to $330 million in Q4 March 2013 over Q4 March 2012. International formulation sales grew by 13% to $73 million in Q4 March 2013 over Q4 March 2012.
Dilip Shanghvi, managing director of the company said, "I am very pleased to announce that, our sales for FY13 have crossed the US$ 2 billion mark. While it took us almost 27 years to record US$ 1 billion in revenues, the next billion was added in just 3 years."
He further said, "All our businesses continue to perform in-line with our expectations. We continue to focus on building a differentiated and specialty product portfolio and enhancing our international presence. Overall, we shall strive to remain focused on execution and building a business with consistent performance."
Meanwhile, the board of Sun Pharma recommended 1:1 bonus issue. Further, the board recommended a dividend of Rs 5 per shares (pre bonus) for the year ended March 2013.
Also Read
Tata Motors, ONGC, Cipla, BPCL, Canara Bank and NMDC unveil their Q4 results today, 29 May 2013.
Hindalco Industries' net profit declined 24.68% to Rs 482 crore on 8.53% fall in revenue from operations to Rs 6994 crore in Q4 March 2013 over Q4 March 2012.
The operational results for Q4 March 2013 showed significant improvement over Q3 December 2012 - EBITDA surged by over 10%. The company delivered sequentially an improved EBITDA in every quarter of this year. The operating margin of the company also grew in Q4 March 2013 by 72 basis points due to operational efficiencies. As a result, net profit has risen by over 11% in Q4 March 2013 over Q3 December 2012, Hindalco said in a statement.
Neyveli Lignite Corporation declined 0.22%. The company's net profit rose 1.58% to Rs 614.79 crore on 1.89% rise in total income to Rs 1858.37 crore in Q4 March 2013 over Q4 March 2012.
HPCL gained 1.12%. The company's net profit jumped 65.82% to Rs 7679.33 crore on 13.81% rise in total income from operations (net) to Rs 59689.99 crore in Q4 March 2013 over Q4 March 2012.
Godrej Industries' consolidated net profit jumped 119% to Rs 94 crore on 0.47% decline in total income to Rs 1472 crore in Q4 March 2013 over Q4 March 2012. The result was announced after market hours on Tuesday, 28 May 2013.
Godrej Industries' consolidated profit before depreciation, interest and taxation (PBDIT) surged 35% to Rs 118 crore in Q4 March 2013 over Q4 March 2012. Profit before tax (PBT) jumped 73% to Rs 78 crore in Q4 March 2013 over Q4 March 2012.
Godrej Industries' consolidated net profit jumped 34% to Rs 391 crore on 24% growth in total income to Rs 7198 crore in the year ended 31 March 2013 (FY 2013) over the year ended 31 March 2012 (FY 2012). PBDIT surged 30% to Rs 596 crore in FY 2013 over FY 2012. PBT surged 47% to Rs 426 crore in FY 2013 over FY 2012.
Commenting on the company's performance in Q4 and FY 2013, Mr. A B Godrej, Chairman, Godrej Industries said, I am pleased to share with you that our overall performance in fiscal year 2012-13 has been good despite economic uncertainty in the global scenario. Our agri businesses recorded encouraging growth in a challenging environment and despite a highly irregular monsoon. With our focus on adding innovative products and with new capacities, our agri businesses will continue on its growth momentum in the years to come. Godrej Seeds, launched last year made good progress during the year and we are positive about its potential. Godrej Properties witnessed a year of strong growth and continued momentum with revenues, booking and net profits growing significantly. Having added 8 new projects in 2013, which include 5 redevelopment projects in Mumbai, we are meaningfully expanding our presence. Further, we have built considerable launch momentum this year with thirteen successful launches across the country including Mumbai, NCR, Bangalore, Pune, Ahmedabad and Kolkata. Our national presence, strong brand equity, differentiated business model and a large number of new projects should enable us to deliver strong growth in the coming years. Godrej Consumer Products had a good year and delivered robust performance in the domestic and international markets. Intensified focus on innovation and backing new products with strong marketing investments has helped us sustain leadership position in our core categories. Going forward, we remain optimistic of continuing the strong growth momentum. For our Chemicals business, it has been a tough year on account of the volatility in the global macro economic environment and raw material price fluctuations. We believe that these challenges are transitory.
At Godrej Industries, we will continue to strengthen our core businesses and harness opportunities in a diverse array of businesses. Our growth-centric strategy has enabled us to create value over the long-term and we are confident of continuing to deliver value for all our stakeholders going forward, Mr. Godrej said.
Godrej Industries' board of directors at a meeting held on Tuesday, 28 May 2013, declared final dividend of Rs 1.75 per share for FY 2013.
Powered by Capital Market - Live News